Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
| 14.25 Delayed Data As of 4:00pm ET |  -0.81 / -5.38%Today’s Change | 11.09 Today|||52-Week Range 22.11 | -23.39% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 500.0K | |
| Depreciation And Amortization | 34.5K | 43.4K | 45.7K | 38.0K | ||
| Operating Expenses | Gross Income | -34.5K | -43.4K | -45.7K | -- | |
| General Expenses | 20.4M | 18.6M | 18.6M | 35.8M | ||
| Research And Development | 11.8M | 11.4M | 11.4M | 19.9M | ||
| Total Operating Expenses | 20.4M | 18.7M | 18.7M | 35.8M | ||
| Non-Operating Expenses | Operating Income | -20.4M | -18.7M | -18.7M | -35.3M | |
| Extraordinary Credit | 65.0K | 886.1K | 0.00 | 0.00 | ||
| Extraordinary Charge | 0.00 | -600.0K | -157.5K | -29.4K | ||
| Other Expenses | 100.4K | 321.6K | 424.7K | 1.3M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -20.2M | -18.1M | -18.4M | -34.0M | |
| Net Income | -20.2M | -18.1M | -18.4M | -34.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 80.9M | 82.9M | 85.8M | 102.6M | |
| Shares To Calculate EPS Diluted | 80.9M | 82.9M | 85.8M | 102.6M | ||
| Earnings Per Share | EPS | -$0.25 | -$0.22 | -$0.21 | -$0.33 | |
| EPS Diluted | -$0.25 | -$0.22 | -$0.21 | -$0.33 | ||
